Margaret Miller, AUD | |
21 Reade Pl, Ste. 3200, Poughkeepsie, NY 12601-3947 | |
(845) 471-4086 | |
Not Available |
Full Name | Margaret Miller |
---|---|
Gender | Female |
Speciality | Audiologist |
Location | 21 Reade Pl, Poughkeepsie, New York |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558626341 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
231H00000X | Audiologist | 002422 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Margaret Miller, AUD 21 Reade Pl, Ste. 3200, Poughkeepsie, NY 12601-3947 Ph: () - | Margaret Miller, AUD 21 Reade Pl, Ste. 3200, Poughkeepsie, NY 12601-3947 Ph: (845) 471-4086 |
News Archive
Spike-protein-based nanoparticle vaccine candidates were retained longer in follicular dendritic cells and showed higher germinal center reactions in lymph node follicles compared to soluble spike protein vaccine.
Funding to fight the spread of HIV/AIDS in Asia and the Pacific has fallen short of the demand, and the majority of available money has missed reaching those at highest risk - Swarup Sarkar, director of Asia unit for the Global Fund to Fight AIDS, Tuberculosis and Malaria - said during a session at the 9th International Congress on AIDS in Asia and the Pacific (ICAAP) in Bali, Indonesia, the Jakarta Post reports.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited today announced that brentuximab vedotin (SGN-35) will be featured in two oral presentations at the 52nd American Society of Hematology (ASH) Annual Meeting and Exposition being held December 4-7, 2010 in Orlando, FL.
BioMarin Pharmaceutical Inc. today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK has completed review of the Clinical Trial Application (CTA) and issued a notice of acceptance for the Phase 3 trial of N-acetylgalactosamine 6-sulfatase (GALNS) for the treatment of Mucopolysaccharidosis IVA (MPS IVA). The company expects to initiate the Phase 3 pivotal trial early in the first quarter of 2011.
› Verified 2 days ago
Dr. Kimberly Anne Emanuele, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 45 Reade Pl, Poughkeepsie, NY 12601 Phone: 845-471-4086 Fax: 845-471-8296 | |
Kristy Tilley, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 201 South Ave, Suite 203, Poughkeepsie, NY 12601 Phone: 845-471-3490 Fax: 845-454-3004 | |
Kimberly Newkirk, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2649 South Rd, Poughkeepsie, NY 12601 Phone: 845-431-8800 Fax: 845-483-5675 | |
Dr. Joyce Fraleigh Dittenhoefer, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 205 South Ave, Suite 202, Poughkeepsie, NY 12601 Phone: 845-485-0179 Fax: 845-485-0187 | |
Karla S. Goddard, MA,CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2649 South Rd, Communations Disorders, Poughkeepsie, NY 12601 Phone: 845-431-8800 Fax: 845-483-5675 | |
Dr. Jennifer Di Tomaso, AU.D Audiologist Medicare: Accepting Medicare Assignments Practice Location: 115 Delafield St, Poughkeepsie, NY 12601 Phone: 845-431-8800 | |
Kathleen Lorena Zory, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 21 Reade Pl Ste 3200, Poughkeepsie, NY 12601 Phone: 845-204-6125 |